Global Lateral Epicondylitis (Tennis
Elbow) Market to Reach Worth USD 10,582.1 Mn by 2022: Rising Prevalence of the
Condition to Determine Market Growth
According
to the latest report published by Credence Research, Inc. “Lateral
Epicondylitis (Tennis Elbow): Market Growth, Future Prospects and Competitive
Analysis, 2016-2022,” the Lateral
Epicondylitis (Tennis Elbow) market was valued at USD 8,104.0 Mn in 2015, and
is expected to reach USD 10,582.1 Mn by 2022, expanding at a CAGR of 3.2% from
2016 to 2022.
Browse the full report Lateral
Epicondylitis (Tennis Elbow): Market Growth, Future Prospects and Competitive
Analysis, 2016-2022 report at http://www.credenceresearch.com/report/lateral-epicondylitis-tennis-elbow-market
Market Insights
Growth
in healthcare investments, prevalence of lateral epicondylitis and growing
high-risk geriatric population are the major factors driving the global market
growth for lateral epicondylitis treatment. North America is the largest
regional market at a market share of over 35% in 2015, and the dominance of
this region is anticipated to continue through 2022. Rising incidence of sports
injuries and high awareness about treatment and management of tennis elbow
together drive the North America lateral epicondylitis market.
Among
the treatment types, corticosteroids injections segment is the most prominent
market in terms of revenue. However, non-surgical therapies such as platelet
rich plasma (PRP), splint elbow brace, ice packs and others will take
approximately 40% market share in 2015. It is reported that around 95% of the
total tennis elbow patients get relief from these therapies and do not need to
opt for other medications and or surgical procedures. PRP is presently being
investigated as it can act as an effective treatment that can heal a variety of
tendon injuries. It possess a high concentration of proteins referred to as
growth factors that can play a significant role in the healing of injuries.
Prevailing research on lateral epicondylitis and PRP is very promising. A few
treatment centers across the globe are integrating PRP injections into the
nonsurgical treatment regime for tendon elbow. Further long-term results will
add on to footprint of this segment in the tennis elbow market.
Browse
all reports from same category @ http://www.credenceresearch.com/industry/biotechnology-market
Surgical
treatments such as arthroscopy and open surgeries are opted as a final remedial
measure for treating tennis elbow. Technological advancements in the nature of
surgical equipment and guidance systems will support the demand for these
treatment methods. Furthermore growing preference for minimally invasive
procedures due to advantages such as quicker recuperation, better safety
outcomes and less blood loss and risk of infection are the major factors that
urge the demand for arthroscopy for tennis elbow treatment.
About Us:
Credence
Research is a worldwide market research and counseling firm that serves driving
organizations, governments, non legislative associations, and not-for-benefits.
We offer our customers some assistance with making enduring enhancements to
their execution and understand their most imperative objectives. Over almost a
century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith (Global Sales
Manager)
Address:
105 N 1st ST #429, SAN JOSE, CA 95103 US
Ph: 1-800-361-8290
No comments:
Post a Comment